STAAR Surgical to Host Investor and Analyst Day on November 8, 2019
November 06 2019 - 7:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, announced today that the Company will
host an Investor and Analyst Day on Friday, November 8, 2019 in New
York City at 8:30 a.m. EST. The event will detail STAAR’s Vision
for the 2020-2022 three-year planning period and include
presentations by ophthalmic surgeons. Due to limited capacity,
attendance at the Investor and Analyst Day is by invitation
only.
A webcast with accompanying slides of a presentation by Caren
Mason, President and CEO of STAAR Surgical, and a presentation by
Dr. Mark Packer will be available on the “Investors” page of the
Company's website at https://www.staar.com/. A replay of the
webcast will also be available on the Company's website following
the event.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 30 years, designs, develops, manufactures and markets
implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients,
lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR’s lens used in
refractive surgery is called an Implantable Collamer® Lens or
“ICL”, which includes the EVO Visian ICL™ product line. More than
1,000,000 Visian® ICLs have been implanted to date and STAAR
markets these lenses in over 75 countries. To learn more about the
ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191106005304/en/
Investors & Media Brian Moore Sr. Director, Investor,
Media Relations and Corporate Development (626) 303-7902, Ext. 3023
bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Mar 2024 to Apr 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Apr 2023 to Apr 2024